… of C-SCLC patients. In present study, we sought pretreatment features especially basic …
We analyzed 613 small-cell lung cancer (SCLC) patients at our institution between January …

… study which included heavily pretreated patients, as 90.3% … rate was 6.5%, the tumor
control rate was 16.2% and the … consideration in patients with pretreated advanced NSCLC [19…

… Objectives: Cytokines are potential new serum markers, especially desirable for malignancies
with poor prognosis like non-small cell lung cancer (NSCLC). Methods: Cytokines, tumor …

… 68 untreated patients with small-cell lung cancer (SCLC) at the time of diagnosis. The patients
were … We found the majority of patients with SCLC to have high pre-treatment serum VEGF …

… of PET in defining pretreatment tumor volume and to assess its utility in the follow-up of
non-small cell lung cancer patients, we performed a prospective study of patients presenting for …

… In the phase I study of ceritinib in Japanese patients with ALK-positive NSCLC, 2 of 4
patients pretreated with alectinib showed a partial response (PR) with ceritinib.17 These …

… pretreatment assessment of patients with cancer. As demonstrated in this study, the pretreatment
mGPS identifies a subgroup of patients … , independent of tumor stage and regardless of …

… of care for patients with advanced non-small cell lung cancer (NSCLC), … pretreated patients.
In this study, the efficacy of pemetrexed and carboplatin as a salvage therapy for patients …

… Pretreatment global QoL and IADL scores, but not ADL and comorbidity, have significant
prognostic value for survival of elderly patients with advanced non–small-cell lung cancer who …

… The current retrospective study was performed in unselected patients referred to a single …
of pre-treatment characteristics on the prognosis of patients with SCLC; b) to define patient …